The research, led by professor Shaochen Chen from the University of California San Diego in the US, addresses one of the biggest challenges in tissue engineering - creating lifelike tissues and organs with functioning networks of blood vessels that can transport blood, nutrients, waste and other biological materials.
Existing technologies are slow, costly and mainly produce simple structures, such as a single blood vessel - a tube, basically. These blood vessels also are not capable of integrating with the body's vascular system.
"3D bioprinting organs can help bridge this gap, and our lab has taken a big step toward that goal," he said.
Researchers 3D printed a vasculature network that can safely integrate with the body's network to circulate blood.
These blood vessels branch out into many series of smaller vessels, similar to the blood vessel structures found in body.
The team developed an innovative bioprinting technology, using homemade 3D printers, to rapidly produce intricate 3D microstructures that mimic the sophisticated designs and functions of biological tissues.
The UV patterns are shined onto a solution containing live cells and light-sensitive polymers that solidify upon exposure to UV light.
The structure is rapidly printed one layer at a time, in a continuous fashion, creating a 3D solid polymer scaffold encapsulating live cells that will grow and become biological tissue.
The entire process takes just a few seconds - a vast improvement over competing bioprinting methods, which normally take hours just to print simple structures. The process also uses materials that are inexpensive and biocompatible.
Using their technology, they printed a structure containing endothelial cells, which are cells that form the inner lining of blood vessels.
The entire structure fits onto a small area measuring 4X5 millimetres, 600 micrometres thick (as thick as a stack containing 12 strands of human hair).
Researchers cultured several structures in lab for a day, then grafted the resulting tissues into skin wounds of mice.
After two weeks, they examined the implants and found that they had successfully grown into and merged with the host blood vessel network, allowing blood to circulate normally.
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
